Literature DB >> 17007012

Upper gastrointestinal function and glycemic control in diabetes mellitus.

Reawika Chaikomin1, Christopher K Rayner, Karen-L Jones, Michael Horowitz.   

Abstract

Recent evidence has highlighted the impact of glycemic control on the incidence and progression of diabetic micro- and macrovascular complications, and on cardiovascular risk in the non-diabetic population. Postprandial blood glucose concentrations make a major contribution to overall glycemic control, and are determined in part by upper gastrointestinal function. Conversely, poor glycemic control has an acute, reversible effect on gastrointestinal motility. Insights into the mechanisms by which the gut contributes to glycemia have given rise to a number of novel dietary and pharmacological strategies designed to lower postprandial blood glucose concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17007012      PMCID: PMC4088160          DOI: 10.3748/wjg.v12.i35.5611

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  162 in total

Review 1.  Acute hyperglycaemia and oxidative stress generation.

Authors:  A Ceriello
Journal:  Diabet Med       Date:  1997-08       Impact factor: 4.359

2.  Physiological hyperglycemia slows gastric emptying in normal subjects and patients with insulin-dependent diabetes mellitus.

Authors:  E Schvarcz; M Palmér; J Aman; M Horowitz; M Stridsberg; C Berne
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

3.  Inhibition of glucose absorption in the rat jejunum: a novel action of alpha-D-glucosidase inhibitors.

Authors:  A J Hirsh; S Y Yao; J D Young; C I Cheeseman
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

Review 4.  The emerging role of post-prandial hyperglycaemic spikes in the pathogenesis of diabetic complications.

Authors:  A Ceriello
Journal:  Diabet Med       Date:  1998-03       Impact factor: 4.359

5.  Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

Authors:  M A Nauck; U Niedereichholz; R Ettler; J J Holst; C Orskov; R Ritzel; W H Schmiegel
Journal:  Am J Physiol       Date:  1997-11

6.  The effect of octreotide on gastric emptying at a dosage used to prevent complications after pancreatic surgery: a randomised, placebo controlled study in volunteers.

Authors:  M I van Berge Henegouwen; T M van Gulik; L M Akkermans; J B Jansen; D J Gouma
Journal:  Gut       Date:  1997-12       Impact factor: 23.059

7.  Effects of 4 weeks' administration of pramlintide, a human amylin analogue, on glycaemia control in patients with IDDM: effects on plasma glucose profiles and serum fructosamine concentrations.

Authors:  R G Thompson; L Pearson; O G Kolterman
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

8.  High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. 20-year follow-up in the Whitehall Study, the Paris Prospective Study, and the Helsinki Policemen Study.

Authors:  B Balkau; M Shipley; R J Jarrett; K Pyörälä; M Pyörälä; A Forhan; E Eschwège
Journal:  Diabetes Care       Date:  1998-03       Impact factor: 19.112

Review 9.  Abnormal gastric and small intestinal motor function in diabetes mellitus.

Authors:  M Samsom; A J Smout
Journal:  Dig Dis       Date:  1997 Jul-Oct       Impact factor: 2.404

10.  Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.

Authors:  L Ranganath; F Norris; L Morgan; J Wright; V Marks
Journal:  Diabet Med       Date:  1998-02       Impact factor: 4.359

View more
  12 in total

Review 1.  Central nervous system control of gastrointestinal motility and secretion and modulation of gastrointestinal functions.

Authors:  Kirsteen N Browning; R Alberto Travagli
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

2.  Yam contributes to improvement of glucose metabolism in rats.

Authors:  Naoto Hashimoto; Takahiro Noda; Sun-Ju Kim; Md Zaidul Islam Sarker; Hiroaki Yamauchi; Shigenobu Takigawa; Chie Matsuura-Endo; Tatsuro Suzuki; Kyu-Ho Han; Michihiro Fukushima
Journal:  Plant Foods Hum Nutr       Date:  2009-09       Impact factor: 3.921

3.  Mechanisms through which a small protein and lipid preload improves glucose tolerance.

Authors:  Domenico Tricò; Simona Baldi; Alberto Tulipani; Silvia Frascerra; Maria Paula Macedo; Andrea Mari; Ele Ferrannini; Andrea Natali
Journal:  Diabetologia       Date:  2015-07-30       Impact factor: 10.122

4.  The effect of dipeptidyl peptidase-4 inhibition on gastric volume, satiation and enteroendocrine secretion in type 2 diabetes: a double-blind, placebo-controlled crossover study.

Authors:  Adrian Vella; Gerlies Bock; Paula D Giesler; Duane B Burton; Denise B Serra; Monica Ligueros Saylan; Carolyn F Deacon; James E Foley; Robert A Rizza; Michael Camilleri
Journal:  Clin Endocrinol (Oxf)       Date:  2008-03-10       Impact factor: 3.478

5.  A break in the brake mechanism in diabetes: a cause of postprandial hyperglycemia.

Authors:  Aaron Vinik; Archana Nakave; Maria del Pilar Silva Chuecos
Journal:  Diabetes Care       Date:  2008-12       Impact factor: 19.112

6.  Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes.

Authors:  Jing Ma; Julie E Stevens; Kimberly Cukier; Anne F Maddox; Judith M Wishart; Karen L Jones; Peter M Clifton; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes Care       Date:  2009-06-18       Impact factor: 19.112

7.  Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.

Authors:  Tongzhi Wu; Michelle J Bound; Beiyi R Zhao; Scott D Standfield; Max Bellon; Karen L Jones; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes Care       Date:  2013-01-28       Impact factor: 19.112

8.  Impaired hyperglycemia-induced delay in gastric emptying in patients with type 1 diabetes deficient for islet amyloid polypeptide.

Authors:  Hans J Woerle; Max Albrecht; Rainer Linke; Silvia Zschau; Christoph Neumann; Mathias Nicolaus; John E Gerich; Burkhard Göke; Joerg Schirra
Journal:  Diabetes Care       Date:  2008-12       Impact factor: 17.152

9.  Modulation of gastrointestinal vagal neurocircuits by hyperglycemia.

Authors:  Kirsteen N Browning
Journal:  Front Neurosci       Date:  2013-11-26       Impact factor: 4.677

10.  α-lipoic acid suppresses neuronal excitability and attenuates colonic hypersensitivity to colorectal distention in diabetic rats.

Authors:  Yan Sun; Pan-Pan Yang; Zhen-Yuan Song; Yu Feng; Duan-Min Hu; Ji Hu; Guang-Yin Xu; Hong-Hong Zhang
Journal:  J Pain Res       Date:  2017-07-14       Impact factor: 3.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.